4//SEC Filing
Feeney John Joseph 4
Accession 0001209191-12-011829
CIK 0001347178other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:59 PM ET
Size
13.3 KB
Accession
0001209191-12-011829
Insider Transaction Report
Form 4
Feeney John Joseph
Acting Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-02-16+7,500→ 15,000 total - Exercise/Conversion
Common Stock
2012-02-16+4,687→ 19,687 total - Sale
Common Stock
2012-02-16$4.65/sh−4,760$22,152→ 14,927 total - Exercise/Conversion
Restricted Stock Unit
2012-02-16−7,500→ 15,000 total→ Common Stock (7,500 underlying) - Exercise/Conversion
Restricted Stock Unit
2012-02-16−4,687→ 14,063 total→ Common Stock (4,687 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.62 to $4.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
- [F4]N/A
- [F5]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2012. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001454240
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:59 PM ET
- Size
- 13.3 KB